A new algorithm helps turn veterinary notes into systemic codes, a development that could help track disease and enable drug trials.
Geneticist Michael Snyder has tracked the expression of his genes for three years, focusing on changes in response to chronic or acute disease.
From the data of more than 40 million births, scientists link paternal age to birth risks and even risks to the mother’s health.
Stanford scientists identified two key genes responsible for the rapid bone growth of deer antlers, a finding that may one day help treat bone disease.
Scientists use a tweaked version of CRISPR gene editing to turn skin cells into neurons, and simultaneously identify neuron-specific genes.
A new variation of gene-editing technology CRISPR allows scientists to reorganize DNA in a cell's nucleus in three dimensions, altering cell function.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
Stanford's WELL for Life programs challenges participants to spend mindfully, in an effort to understand the relationship between well-being and finances.
Scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, a new study has found.
Scientists have measured the human “exposome,” or the particulates, chemicals, and microbes that individually swarm us all, in unprecedented detail.
PHIND scientists discuss how to stop disease in its track, aiming for earlier diagnostics and more precise medical treatments.
John Ioannidis reflects on the phenomenon of "hyper-publishing," where certain scientists are listed as authors on scores of papers a year.
The true driver mutations of cancer are almost always common to all metastases in an individual, according to a Stanford scientist and other researchers.
Scientists have developed an algorithm that combines genome sequence data and electronic health information to predict risk for genetic disease.
Scientists review the compliance of pharmacies and tobacco-selling policies, finding that Walgreens is the most likely to sell to minors.
John Farquhar, a beloved mentor, and pioneer in cardiovascular disease prevention at Stanford, died Aug. 22 at the age of 91.
